Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament
The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that t...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | nor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Toporisic, Rebeka Kastelic, Joze Lakse, Renata |
description | The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that the contact of the compositions with oxygen is substantially reduced, such as by coating the composition, providing a medicament useful for the treatment and prevention of atherosclerosis and related conditions, in an environment having an essentially reduced oxygen or humidity, respectively, content. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO340496BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO340496BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO340496BB13</originalsourceid><addsrcrecordid>eNqNzDEKwkAQheE0FqLeYQ6goCQIthGDlTb2YTSzYcjObtgZAnoyey9mAh7A6vHg459nvsIkqJ_301g7UBShoGSBQwtRHJpRaAiUZUA1NA4QW6AXGQvf19PBMEzGK4GLCVwiUWPvpwQOINRwh2PWltnM4chWv11kUJ1ux_OG-liT9vigQFZfrnmxLQ77stzlf5Av63pDhA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament</title><source>esp@cenet</source><creator>Toporisic, Rebeka ; Kastelic, Joze ; Lakse, Renata</creator><creatorcontrib>Toporisic, Rebeka ; Kastelic, Joze ; Lakse, Renata</creatorcontrib><description>The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that the contact of the compositions with oxygen is substantially reduced, such as by coating the composition, providing a medicament useful for the treatment and prevention of atherosclerosis and related conditions, in an environment having an essentially reduced oxygen or humidity, respectively, content.</description><language>nor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170502&DB=EPODOC&CC=NO&NR=340496B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170502&DB=EPODOC&CC=NO&NR=340496B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Toporisic, Rebeka</creatorcontrib><creatorcontrib>Kastelic, Joze</creatorcontrib><creatorcontrib>Lakse, Renata</creatorcontrib><title>Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament</title><description>The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that the contact of the compositions with oxygen is substantially reduced, such as by coating the composition, providing a medicament useful for the treatment and prevention of atherosclerosis and related conditions, in an environment having an essentially reduced oxygen or humidity, respectively, content.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzDEKwkAQheE0FqLeYQ6goCQIthGDlTb2YTSzYcjObtgZAnoyey9mAh7A6vHg459nvsIkqJ_301g7UBShoGSBQwtRHJpRaAiUZUA1NA4QW6AXGQvf19PBMEzGK4GLCVwiUWPvpwQOINRwh2PWltnM4chWv11kUJ1ux_OG-liT9vigQFZfrnmxLQ77stzlf5Av63pDhA</recordid><startdate>20170502</startdate><enddate>20170502</enddate><creator>Toporisic, Rebeka</creator><creator>Kastelic, Joze</creator><creator>Lakse, Renata</creator><scope>EVB</scope></search><sort><creationdate>20170502</creationdate><title>Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament</title><author>Toporisic, Rebeka ; Kastelic, Joze ; Lakse, Renata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO340496BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Toporisic, Rebeka</creatorcontrib><creatorcontrib>Kastelic, Joze</creatorcontrib><creatorcontrib>Lakse, Renata</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Toporisic, Rebeka</au><au>Kastelic, Joze</au><au>Lakse, Renata</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament</title><date>2017-05-02</date><risdate>2017</risdate><abstract>The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that the contact of the compositions with oxygen is substantially reduced, such as by coating the composition, providing a medicament useful for the treatment and prevention of atherosclerosis and related conditions, in an environment having an essentially reduced oxygen or humidity, respectively, content.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | nor |
recordid | cdi_epo_espacenet_NO340496BB1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Farmasøytisk sammensetning omfattende simvastatin og ezetimib, og anvendelse for fremstilling av medikament |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T22%3A29%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Toporisic,%20Rebeka&rft.date=2017-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO340496BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |